Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID19, Cochrane Library
Cochrane Review by Bhagteshwar Singh and colleagues definitively concludes that hydroxychloroquine has no clinical benefit in treating COVID ‐19 in hospitalized patients. 2 External 0 0 0 [ false https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.ED000151/full#ED000151-bib-0001 true false%> 2 External 0 0 0 1 false https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.ED000151/full#ED000151-bib-0001 true false%>] The dissemination of information on these drugs in the scientific press and other media has been rapid and tumultuous with strong and polarized opinions among scientists, politicians, and the ge...
Source: Current Awareness Service for Health (CASH) - April 1, 2021 Category: Consumer Health News Source Type: news

Hydroxychloroquine valid option in autoantibody-negative rheumatoid arthritis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news

After one year attacking vaccine efforts and promoting hydroxychloroquine, Bolsonaro makes a TV statement lying about his goverment actions
President changes tone on the day that Brazil registers more than 3,000 deaths by Covid and declares 2021 year of the vaccine (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2021 Category: Consumer Health News Source Type: news

Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID19 pandemic, BJCP
Analysis found that the 51 registered RCTs investigating hydroxychloroquine or chloroquine during the early stages of the COVID ‐19 pandemic included heterogeneous and insufficient approaches to measure efficacy/effectiveness and safety relevant to patients and clinical practice. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 24, 2021 Category: Consumer Health News Source Type: news

The Quinism Foundation Encourages Those Injured by Hydroxychloroquine...
The Foundation has Written to Newly Confirmed Secretary of Health and Human Services, Xavier Becerra, Encouraging Liberal Consideration of Claims under the Countermeasures Injury Compensation Program(PRWeb March 19, 2021)Read the full story at https://www.prweb.com/releases/the_quinism_foundation_encourages_those_injured_by_hydroxychloroquine_and_related_quinoline_antimalarial_drugs_to_file_timely_claims_for_government_compensation/prweb17811259.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2021 Category: Pharmaceuticals Source Type: news

Cochrane Library Editorial - Contested effects and chaotic policies: the 2020 story of (hydroxy) chloroquine for treating COVID-19
During the past 12 months chloroquine and hydroxychloroquine have been touted as cures for COVID-19 and introduced into Covid-19 treatment protocols. This has led to increases in demand, leaving some rheumatoid arthritis and lupus patients deprived of effective treatments.A newly publishedCochrane Library Editorial explores the story of the assessment of  chloroquine and hydroxychloroquine efficacy and the lessons learnt. This Editorial publishes alongside the  recently published review published in the Cochrane Library   that concludes that hydroxychloroquine   has no clinical benefit in...
Source: Cochrane News and Events - March 9, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Chloroquine or hydroxychloroquine for prevention and treatment of COVID19, Cochrane Database of Systematic Reviews
Review (12 RCTs; n= 8569) found hydroxychloroquine has minimal effect on risk of mortality, no effect on progression to mechanical ventilation, and is associated with triple the number of adverse events vs placebo, therefore no further treatment trials should be carried out. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 9, 2021 Category: Consumer Health News Source Type: news

The end of hydroxychloroquine as a treatment for COVID-19
(University of Washington School of Medicine/UW Medicine) A year ago, infectious disease doctor Christine Johnston was leading a study on the use of hydroxychloroquine for the treatment of people with COVID-19. A year later, her team published results that showed the drug -- once a political football -- had no effect. Johnston talks about lessons learned under the world spotlight. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 9, 2021 Category: Infectious Diseases Source Type: news

WHO Recommends Against Hydroxychloroquine To Prevent Covid-19, Oklahoma Is Stuck With Piles Of It
Oklahoma is apparently trying to negotiate a return of 1.2 million hydroxychloroquine pills that the state purchased last year for around $2 million. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 6, 2021 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

WHO Advises Against Hydroxychloroquine to Prevent COVID-19 WHO Advises Against Hydroxychloroquine to Prevent COVID-19
The recommendations are based on evidence from six randomised controlled trials involving over 6,000 participants with and without known exposure to a person with COVID-19 infection.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 4, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Societies Issue Joint Statement on Safe Use of HCQ Societies Issue Joint Statement on Safe Use of HCQ
Hydroxychloroquine can be used safely and effectively with attention to dosing, risk factors, and screening, but communication among physicians, patients, and eye care specialists is key.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 3, 2021 Category: Dermatology Tags: Infectious Diseases News Source Type: news

WHO panel issues strong advice against hydroxychloroquine for COVID-19
The drug hydroxychloroquine, once touted by former U.S. president Donald Trump as a pandemic "game-changer," should not be used to prevent COVID-19 and has no meaningful effect on patients already infected, a World Health Organization expert panel said on Tuesday. (Source: CBC | Health)
Source: CBC | Health - March 2, 2021 Category: Consumer Health News Tags: News/World Source Type: news

WHO panel: Hydroxychloroquine should not be used to prevent COVID-19
The anti-inflammatory drug hydroxychloroquine should not be used to prevent COVID-19, according to a new recommendation from the World... (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2021 Category: Consumer Health News Source Type: news

WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19
(BMJ) The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts inThe BMJ today. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 1, 2021 Category: International Medicine & Public Health Source Type: news

Is chloroquine or hydroxychloroquine useful in treating people with COVID-19, or in preventing infection in people who have been exposed to the virus?
COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.Drugs used for other diseases were tried out in COVID-19, and this included chloroquine, used for malaria; and hydroxychloroquine used for rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus. The authors sought evidence of the effects of these drugs in treating people ill with the disease; in preventing the disease in people at risk of getting the disease, such as health workers; and peo...
Source: Cochrane News and Events - February 10, 2021 Category: Information Technology Authors: Katie Abbotts Source Type: news

NIH Director Francis Collins Is Fighting This Coronavirus While Preparing for the Next One
In May 2020, Dr. Francis Collins, the longtime head of the National Institutes of Health (NIH), was called to the White House to meet with Jared Kushner, the then President’s son-in-law and adviser, and Dr. Deborah Birx, the head of the White House Coronavirus Task Force. A few weeks earlier, Congress had given the NIH $1.5 billion to try to speed up the process of developing new diagnostic tests for COVID-19, and the White House, which was dubious about increasing the rate of testing, wanted to know more about what the NIH was doing. Collins is technically the boss of Dr. Anthony Fauci, but during the pandemic he ha...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized COVID-19 feature Magazine Source Type: news

After 440,000 Americans reportedly died, mainstream media and Big Tech finally admit hydroxychloroquine works
(Natural News) Now that it is way too late for the nearly half a million people in America who already died after testing positive for the Wuhan coronavirus (COVID-19), Facebook, the American Journal of Medicine (AJM), and other Big Media and Big Tech outlets are suddenly coming clean about being dead wrong concerning the safety... (Source: NaturalNews.com)
Source: NaturalNews.com - February 1, 2021 Category: Consumer Health News Source Type: news

How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead
Vaccine development exceeded everyone ’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them. (Source: NYT Health)
Source: NYT Health - January 30, 2021 Category: Consumer Health News Authors: Carl Zimmer Tags: Clinical Trials Coronavirus (2019-nCoV) Hydroxychloroquine (Drug) Drugs (Pharmaceuticals) Research your-feed-healthcare Remdesivir (Drug) Source Type: news

Oklahoma seeking to return $2M worth of hydroxychloroquine
Oklahoma is attempting to return $2 million worth of hydroxychloroquine (Source: ABC News: Health)
Source: ABC News: Health - January 27, 2021 Category: Consumer Health News Tags: Health Source Type: news

Adverse Drug Reactions Linked to Hydroxychloroquine Up in 2020
WEDNESDAY, Jan. 27, 2021 -- The number of adverse drug reactions (ADRs) associated with hydroxychloroquine and chloroquine more than doubled in 2020 compared with 2018 and 2019, according to a research letter published online Jan. 26 in the Annals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2021 Category: Pharmaceuticals Source Type: news

Simone Gold, who advocated hydroxychloroquine as a remedy for coronavirus, arrested in connection to Capitol "riot"
(Natural News) The left-wing media is having a heyday with the news that America’s Frontline Doctors head Dr. Simone Gold was arrested for having appeared at the United States Capitol on Jan. 6. Dr. Gold was present with her megaphone to deliver a speech about the dangers and ineffectiveness of Wuhan coronavirus (COVID-19) vaccines, urging... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2021 Category: Consumer Health News Source Type: news

Pustulosis, Stevens-Johnson Syndrome Due to Hydroxychloroquine Pustulosis, Stevens-Johnson Syndrome Due to Hydroxychloroquine
This case draws attention to the possibility of severe adverse cutaneous drug reactions to hydroxychloroquine and the necessity for caution when using hydroxychloroquine to manage COVID-19.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 20, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report, European Journal of Hospital Pharmacy
Portuguese study reported a greater incidence of adverse drug reactions with hydroxychloroquine vs remdesivir (n=149; total of 102 events; 47.5% vs 12.5%; p (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 19, 2021 Category: Consumer Health News Source Type: news

Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
Rate of thrombotic events lower for patients with mean HCQ blood levels>1,068 versus
Source: The Doctors Lounge - Oncology - January 11, 2021 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Oncology, Pathology, Pharmacy, Rheumatology, Journal, Source Type: news

Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
MONDAY, Jan. 11, 2021 -- For patients with systemic lupus erythematosus (SLE), lower hydroxychloroquine (HCQ) blood levels are associated with a higher risk for thrombotic events, according to a study published online Jan. 5 in Arthritis&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2021 Category: Pharmaceuticals Source Type: news

Hydroxychloroquine blood levels predict clotting risk in patients with lupus
(Wiley) A new study in Arthritis& Rheumatology shows that monitoring patients' blood levels of hydroxychloroquine can predict their clotting risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2021 Category: International Medicine & Public Health Source Type: news

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study - Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MTF, Alghoul H, Alser O, Alshammari TM, Areia C, Biedermann P, Banda JM, Burn E, Casajust P, Fister K, Hardin J, Hester L, Hripcsak G, Kaas-Hansen BS, Khosla S, Kolovos S, Lynch KE, Makadia R, Mehta PP, Morales DR, Morgan-Stewart H, Mosseveld M, Newby D, Nyberg F, Ostropolets A, Woong Park R, Prats-Uribe A, Rao GA, Reich C, Rijnbeek P, Sena AG, Shoaibi A, Spotnitz M, Vignesh S, Suchard MA, Vizcaya D, Wen H, de Wilde M, Xie J, You SC, Zhang L, Lovestone S, Ryan P, Prieto-Alhambra D.
OBJECTIVES: Concern has been raised in the rheumatology community regarding recent regulatory warnings that HCQ used in the coronavirus disease 2019 pandemic could cause acute psychiatric events. We aimed to study whether there is risk of incident depre... (Source: SafetyLit)
Source: SafetyLit - December 31, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Pharmaceutical factory that manufactures hydroxychloroquine mysteriously bursts into flames, explodes
(Natural News) On Dec. 20, an SCI Pharmtech manufacturing facility in Taoyuan City, Taiwan, burst into flames and exploded, leaving two people injured. The facility, which manufactures the anti-Wuhan coronavirus (COVID-19) drug hydroxychloroquine, appears to have been targeted, perhaps by COVID-19 vaccine interests, in an effort to punish the company for manufacturing the inexpensive, highly... (Source: NaturalNews.com)
Source: NaturalNews.com - December 24, 2020 Category: Consumer Health News Source Type: news

WHO publishes updated living guideline on therapeutics and Covid-19, WHO
Based on the results of a systematic review and meta-analysis, the guideline panel makes new strong recommendations against the use of hydroxychloroquine and lopinavir/ritonavir in patients with Covid-19, regardless of disease severity. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 21, 2020 Category: Consumer Health News Source Type: news

Physician Indicted for Selling Hydroxychloroquine as COVID Cure Physician Indicted for Selling Hydroxychloroquine as COVID Cure
The doctor faces up to 20 years in prison on allegations of fraudulently obtaining hydroxychloroquine and selling it with other drugs in anti-COVID-19 kits.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 18, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Doctor Selling COVID-19 “Cure” Charged with Lying to U.S. Customs, Stealing Employee’s Identity
FDA OCI, Jennings Staley M.D., COVID-19, coronavirus, hydroxychloroquine, miracle cure, treatment kit, Chinese supplier, smuggle, Skinny Beach Med Spa, mail fraud, identity theft, bogus Rx, magic bullet, 100% effective cure, sham, bogus, prescription, yam extract, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 11, 2020 Category: Medical Law Authors: DOJ Source Type: news

Doctor Selling COVID-19 “Cure” Charged with Lying to U.S. Customs, Stealing Employee’s Identity
FDA OCI, Jennings Staley MD, charged, lying, miracle cure, Skinny Beach Med Spas, COVID-19, coronavirus, smuggle, hydroxychloroquine, treatment kit, mefloquine, "Russian cure", China, suppliers, San Diego, mail fraud, employee identity, stolen, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 7, 2020 Category: Medical Law Authors: DOJ Source Type: news

COVID-19 news from Annals of Internal Medicine
(American College of Physicians) 1. Hydroxychloroquine shows no benefit for postexposure prophylaxis for preventing SARS-CoV-2 infection ; 2. Patients with COVID-19 may develop an array of symptoms that evolve over time ; 3. Wuhan study helps researchers better understand SARS-CoV-2 positivity and the disease course of COVID-19 ; 4. Simultaneous COVID-19 infection in identical twins helps to explain differences in illness severity ; 5. Caring for dying patients during the pandemic shows the human side of medicine (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 7, 2020 Category: Infectious Diseases Source Type: news

Anti-Vaccine Doctor Has Been Invited to Testify Before Senate Committee
The selection of Dr. Jane M. Orient as federal health officials are trying to promote a vaccine to end the coronavirus pandemic prompted harsh criticism from Senator Chuck Schumer, Democrat of New York. (Source: NYT Health)
Source: NYT Health - December 7, 2020 Category: Consumer Health News Authors: Sheryl Gay Stolberg Tags: Orient, Jane M. Senate Committee on Homeland Security and Governmental Affairs Coronavirus (2019-nCoV) Vaccination and Immunization Hydroxychloroquine (Drug) Conspiracy Theories Assn of American Physicians and Surgeons United States Politics Source Type: news

Antiviral Drugs Have No Effect on Mortality in COVID - 19
Remdesivir, hydroxychloroquine, lopinavir, interferon regimens have little to no effect on in - hospital mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 4, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Antiviral Drugs Have No Effect on Mortality in COVID-19
FRIDAY, Dec. 4, 2020 -- For hospitalized patients with COVID-19, remdesivir, hydroxychloroquine, lopinavir, and interferon regimens seem to have little to no effect on mortality, according to a study published online Dec. 2 in the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 4, 2020 Category: Pharmaceuticals Source Type: news

Analysis finds four repurposed antiviral drugs have little or no effect on patients hospitalised for COVID-19
Repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon - to treat COVID-19 appear to have little or no effect on patients hospitalised for the disease, in terms of overall mortality, initiation of ventilation and duration of hospital stay. The interim findings from the WHO Solidarity trial, published in the New England Journal of Medicine (NEJM), followed 11,266 adults at 405 hospitals in 30 countries. (Source: University of Bristol news)
Source: University of Bristol news - December 4, 2020 Category: Universities & Medical Training Tags: Research, International, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Systemic Lupus Erythematosus Abstracts From ACR Convergence Systemic Lupus Erythematosus Abstracts From ACR Convergence
Dr Michele Petri highlights abstracts on systemic lupus erythematosus from ACR 2020, including the effects of hydroxychloroquine on QTc length and use of belimumab and obinutuzumab on renal outcomes.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news

US Presidential Election Part 3: President Trump ’s Legacy of Mismanagement of the Pandemic
Credit: Whitehouse.GovBy Farhang JahanpourOXFORD, Dec 1 2020 (IPS) Covid-19 is on track to be the deadliest and one of the most catastrophic epidemics since the 1918-1919 flu pandemic, which infected about 500 million people or one-third of the world’s population at the time. The number of deaths was estimated somewhere between 17 and 50 million, and possibly as high as 100 million worldwide. The first observations of illness and mortality were documented in December 1917 at Camp Greene, North Carolina. To maintain morale, World War I censors minimized reports of casualties, but as newspapers in neutral Spain were f...
Source: IPS Inter Press Service - Health - December 1, 2020 Category: International Medicine & Public Health Authors: Farhang Jahanpour Tags: Democracy Global Geopolitics Headlines Health North America TerraViva United Nations Source Type: news

Update to information on psychiatric disorders for chloroquine and hydroxychloroquine, EMA
EMA's safety committee (PRAC) has recommended updating product information for all chloroquine or hydroxychloroquine-containing medicines following a review that confirmed a link between the use of these medicines and the risk of psychiatric disorders and suicidal behaviour. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2020 Category: Consumer Health News Source Type: news

Rutgers leading coronavirus therapeutic clinical trial
(Rutgers University) Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

Mechanism of action of chloroquine/hydroxychloroquine for COVID-19 infection
(Bentham Science Publishers) The recent serious outbreak of Covid19 has required urgent medical treatments for numerous patients. No clinically active vaccines or antiviral agents are available for Covid19. According to several studies, Chloroquine (CQ) and Hydroxychloroquine (HCQ) have shown promises as Covid19 antiviral especially when administered with Azithromycin (AZM). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 30, 2020 Category: Infectious Diseases Source Type: news

COVID-19: A data challenge and a catalyst for new insights
  One of the key issues that arose during the pandemic, and arguably a factor that has led to more deaths, has been one of healthcare systems, public health and governments having insufficient or no relevant data on which to base critical decisions. The right data are not in the right place to answer the right questions at the right time. Yet, in the midst of this we have also seen remarkable collaboration on the scientific response to the pandemic, from diagnostics to therapeutic and vaccine research and development. We have learned a lot about the virus since its genome was shared by Chinese researchers in Jan...
Source: EyeForPharma - November 24, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Hydroxychloroquine doesn ’t benefit hospitalized COVID-19 patients
In a final analysis of study data, researchers concluded that the medication hydroxychloroquine provides no benefit to adults hospitalized with COVID-19. (Source: NIH Research Matters)
Source: NIH Research Matters - November 23, 2020 Category: Research Source Type: news

New insight into the effect of hydroxychloroquine undermines its use in COVID-19
(Radboud University Medical Center) Researchers at Radboud university medical center have discovered an as yet unknown effect of hydroxychloroquine. It inhibits the action of a type of white blood cells important in the first line of defense against infections. Based on this research, hydroxychloroquine is unlikely to be beneficial in clearing viral infections including the new coronavirus SARS-CoV-2, they write in their publication inCell Reports Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 23, 2020 Category: Infectious Diseases Source Type: news

Methotrexate and HCQ Split on Cardiovascular Outcomes in RA Methotrexate and HCQ Split on Cardiovascular Outcomes in RA
No significant differences in major adverse cardiovascular events emerged between methotrexate and hydroxychloroquine treatment in a comparison of adults 65 years or older with rheumatoid arthritis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 13, 2020 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
(Vanderbilt University Medical Center) Findings from a national study published today in the Journal of the American Medical Association (JAMA) " do not support " the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 13, 2020 Category: Infectious Diseases Source Type: news

Coronavirus live news: quarter of deaths in France linked to Covid as US tops 140,000 daily cases
France ’s lockdown extended by two weeks; German infection surge may be easing; Russia says its Sputnik-V vaccine is 92% effectiveScientist behind BioNTech/Pfizer vaccine says it can end pandemicBillionaire Trump donors contract Covid after playing down risksCovid infections in Sweden surge, dashing hopes of herd immunityFrench professor faces disciplinary case over hydroxychloroquine claims1.04amGMTOne of the first cruise ships to ply throughCaribbean waters since the pandemic began ended its trip early after five passengers tested positive for Covid-19.The SeaDream is carrying 53 passengers and 66 crew, with the ma...
Source: Guardian Unlimited Science - November 13, 2020 Category: Science Authors: Helen Sullivan Tags: Coronavirus World news Europe UK news US news Science Infectious diseases Source Type: news

French professor faces disciplinary case over hydroxychloroquine claims
Didier Raoult stands accused of touting drug as a coronavirus treatment without evidence (Source: Reuters: Health)
Source: Reuters: Health - November 12, 2020 Category: Consumer Health News Source Type: news

NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19
THURSDAY, Nov. 12, 2020 -- Hydroxychloroquine is not beneficial for adults hospitalized with COVID-19, according to the formal conclusion of a study funded by the U.S. National Heart, Lung, and Blood Institute (NHLBI) and published online Nov. 9 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 12, 2020 Category: Pharmaceuticals Source Type: news